Parametric Portfolio Associates’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$122K Buy
+10,878
New +$92.7K ﹤0.01% 3532
2021
Q4
Sell
-16,346
Closed -$125K 3656
2021
Q3
$125K Buy
16,346
+2,022
+14% +$20.9K ﹤0.01% 3504
2021
Q2
$181K Buy
14,324
+3,422
+31% +$37.6K ﹤0.01% 3423
2021
Q1
$142K Buy
+10,902
New +$100K ﹤0.01% 3935
2020
Q4
Sell
-11,469
Closed -$45K 4006
2020
Q3
$45K Sell
11,469
-2,775
-19% -$10.1K ﹤0.01% 3873
2020
Q2
$75K Buy
+14,244
New +$65.6K ﹤0.01% 3823
2019
Q4
Sell
-10,863
Closed -$170K 3971
2019
Q3
$170K Buy
+10,863
New +$178K ﹤0.01% 3745
2019
Q2
Sell
-36,914
Closed -$833K 3967
2019
Q1
$833K Buy
+36,914
New +$798K ﹤0.01% 3113
2018
Q3
Sell
-18,537
Closed -$519K 3948
2018
Q2
$519K Buy
+18,537
New +$327K ﹤0.01% 3329

Other funds holding EOLS

Parametric Portfolio Associates's EOLS Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Evolus (EOLS) in Q1 2022: 10,878 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #3532 among its holdings. This is a return to the name: Parametric Portfolio Associates previously reported a position in EOLS as recently as Q3 2021.

Parametric Portfolio Associates first reported a position in EOLS in Q2 2018 and has held it in 9 quarters since. The position peaked at $833K in Q1 2019. 118 funds tracked by Wall St. Rank hold EOLS as of Q1 2022.

  • Parametric Portfolio Associates held 10,878 shares of Evolus worth $122K as of Q1 2022.
  • Evolus was a new Parametric Portfolio Associates position in Q1 2022.
  • Evolus made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3532 holding.
  • Parametric Portfolio Associates first reported a position in Evolus in Q2 2018 and has held it in 9 quarters since.
  • Parametric Portfolio Associates's Evolus position peaked at $833K in Q1 2019.
  • 118 funds tracked by Wall St. Rank held Evolus as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.